Resources

The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry

Target Based Discovery

Navigating DEL Screening from Hit to Lead

The panel at Drug Discovery US discussed hit finding technologies, protein availability for screening, and hit-to-lead transition.
Neuroscience Discovery

Challenges in Developing Organoids for Neuroscience

Oxford Global’s panel discussion: Translational Models from 3D to Animal Model of Disease – Neuroscience, asked experts to share their experience of developing organoids for translational neuroscience.
Organ Modelling Discovery

Cultrex™ Extracellular Matrix And Proteins

CultrexTM Basement Membrane Extract (BME)
Neuroscience Discovery

Prothena and Evotec Score Major Deals with Bristol Myers Squibb for Neuroscience Breakthroughs

Prothena will receive $55 million to license its clinical Alzheimer's drug candidate, while Evotec will receive $40 million for its late-stage clinical programs.
Pharma Data

A Guide to Successful Real World Evidence Implementation

How can you overcome challenges and unleash the potential of Real-World Evidence for impactful healthcare insights?
Organ Modelling Discovery

Scientists Create Transparent Mouse to Advance Preclinical Medicine

The method, known as tissue clearing and immunolabeling, enables the detection of tumours at the single-cell level.
AI, Machine Learning & Computational Drug Design

What is AlphaFold?

AlphaFold is the protein folding solution that took computational biology by storm, but has the protein folding problem been well and truly solved?
Organ Modelling Discovery

Newcells Products and Services

We build custom, functional in vitro models, mimicking in vivo physiology, to improve clinical translation and accelerate drug discovery
Targeted Protein Degradation

Interview with Yusuke Tominari, Co founder and CEO of Fimecs

Yusuke will be giving a keynote presentation at Discovery Europe 2023 titled 'Targeted Protein Degradation And Addressing Undruggable Targets'.
Target Based Discovery

Admescope: a Symeres Company

Your ADME-Tox Research Partner
Target Based Discovery

Tailor-made ADME-Tox

Admescope is a contract research organisation (CRO) providing the pharmaceutical industry with tailor-made ADME-Tox services to support the discovery and development of small molecules and biologics.
Organ Modelling Discovery

Cultrex™ Products for Physiologic Cell Culture

R&D Systems products for physiologic cell culture recreate tissue microenvironments to elicit in vivo structure and function for cells in vitro.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery